Neutral
PTC Therapeutics CEO Matthew Klein sells $202,093 in stock By Investing.com
PTC Therapeutics CEO Matthew Klein sold 2,850 shares of the company's common stock for $202,093 on April 21, 2026. This "sell to cover" transaction wa...